First person – Sabrina Yahiya

Abstract

ABSTRACT First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Sabrina Yahiya is first author on ‘ A novel class of sulphonamides potently block malaria transmission by targeting a Plasmodium vacuole membrane protein’, published in DMM. Sabrina conducted the research described in this article while a PhD candidate in Prof. Jake Baum's lab at Imperial College London, UK. She is now a scientist in the Infectious Diseases & Vaccines Group at Kymab, a Sanofi company, in Cambridge, UK, and is interested in the development of therapeutics targeting infectious diseases, with a focus on blocking malaria transmission.